Advanced

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

Meijer, Chris J. L. M.; Berkhof, Johannes; Castle, Philip E.; Hesselink, Albertus T.; Franco, Eduardo L.; Ronco, Guglielmo; Arbyn, Marc; Bosch, F. Xavier; Cuzick, Jack and Dillner, Joakim LU , et al. (2009) In International Journal of Cancer 124(3). p.516-520
Abstract
Given the strong etiologic link between high-risk HPV infection and cervical cancer high-risk HPV testing is now being considered as an alternative for cytology-based cervical cancer screening. Many test systems have been developed that can detect the broad spectrum of hrHPV types in one assay. However, for screening purposes the detection of high-risk HPV is not inherently useful unless it is informative for the presence of high-grade cervical intraepithelial neoplasia (CIN 2/3) or cancer. Candidate high-risk HPV tests to be used for screening should reach an optimal balance between clinical sensitivity and specificity for detection of high-grade CIN and cervical cancer to minimize redundant or excessive follow-up procedures for high-risk... (More)
Given the strong etiologic link between high-risk HPV infection and cervical cancer high-risk HPV testing is now being considered as an alternative for cytology-based cervical cancer screening. Many test systems have been developed that can detect the broad spectrum of hrHPV types in one assay. However, for screening purposes the detection of high-risk HPV is not inherently useful unless it is informative for the presence of high-grade cervical intraepithelial neoplasia (CIN 2/3) or cancer. Candidate high-risk HPV tests to be used for screening should reach an optimal balance between clinical sensitivity and specificity for detection of high-grade CIN and cervical cancer to minimize redundant or excessive follow-up procedures for high-risk HPV positive women without cervical lesions. Data from various large screening studies have shown that high-risk HPV testing by hybrid capture 2 and GP5+/6+-PCR yields considerably better results in the detection of CIN 2/3 than cytology. The data from these studies can be used to guide the translation of high-risk HPV testing into clinical practice by setting standards of test performance and characteristics. On the basis of these data we have developed guidelines for high-risk HPV test requirements for primary cervical screening and validation guidelines for candidate HPV assays. (C) 2008 Wiley-Liss, Inc. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
requirements, HPV test, HPV test guidelines, HPV-DNA testing, cervical screening, HPV test statistics
in
International Journal of Cancer
volume
124
issue
3
pages
516 - 520
publisher
John Wiley & Sons
external identifiers
  • wos:000262205400002
  • scopus:58149292268
ISSN
0020-7136
DOI
10.1002/ijc.24010
language
English
LU publication?
yes
id
021853ca-60d7-4c63-bd2f-524ac5ad01ae (old id 1313344)
date added to LUP
2009-03-12 09:57:47
date last changed
2017-12-17 03:23:14
@article{021853ca-60d7-4c63-bd2f-524ac5ad01ae,
  abstract     = {Given the strong etiologic link between high-risk HPV infection and cervical cancer high-risk HPV testing is now being considered as an alternative for cytology-based cervical cancer screening. Many test systems have been developed that can detect the broad spectrum of hrHPV types in one assay. However, for screening purposes the detection of high-risk HPV is not inherently useful unless it is informative for the presence of high-grade cervical intraepithelial neoplasia (CIN 2/3) or cancer. Candidate high-risk HPV tests to be used for screening should reach an optimal balance between clinical sensitivity and specificity for detection of high-grade CIN and cervical cancer to minimize redundant or excessive follow-up procedures for high-risk HPV positive women without cervical lesions. Data from various large screening studies have shown that high-risk HPV testing by hybrid capture 2 and GP5+/6+-PCR yields considerably better results in the detection of CIN 2/3 than cytology. The data from these studies can be used to guide the translation of high-risk HPV testing into clinical practice by setting standards of test performance and characteristics. On the basis of these data we have developed guidelines for high-risk HPV test requirements for primary cervical screening and validation guidelines for candidate HPV assays. (C) 2008 Wiley-Liss, Inc.},
  author       = {Meijer, Chris J. L. M. and Berkhof, Johannes and Castle, Philip E. and Hesselink, Albertus T. and Franco, Eduardo L. and Ronco, Guglielmo and Arbyn, Marc and Bosch, F. Xavier and Cuzick, Jack and Dillner, Joakim and Heideman, Danielle A. M. and Snijders, Peter J. F.},
  issn         = {0020-7136},
  keyword      = {requirements,HPV test,HPV test guidelines,HPV-DNA testing,cervical screening,HPV test statistics},
  language     = {eng},
  number       = {3},
  pages        = {516--520},
  publisher    = {John Wiley & Sons},
  series       = {International Journal of Cancer},
  title        = {Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older},
  url          = {http://dx.doi.org/10.1002/ijc.24010},
  volume       = {124},
  year         = {2009},
}